Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Unicycive Therapeutics, Inc. | CEO, Director | Stock Options | 6.44M | Aug 12, 2024 | Direct | ||
Unicycive Therapeutics, Inc. | CEO, Director | Stock Options | 6.21M | Apr 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
UNCY | Unicycive Therapeutics, Inc. | Aug 12, 2024 | 1 | $0 | 4 | Aug 14, 2024 | CEO, Director |
UNCY | Unicycive Therapeutics, Inc. | Apr 15, 2024 | 1 | $0 | 4 | Apr 17, 2024 | CEO, Director, 10%+ Owner |
UNCY | Unicycive Therapeutics, Inc. | Aug 28, 2023 | 1 | $0 | 4 | Aug 30, 2023 | CEO, Director |
UNCY | Unicycive Therapeutics, Inc. | Jul 11, 2023 | 5 | -$50K | 4 | Jul 13, 2023 | CEO, Director |
UNCY | Unicycive Therapeutics, Inc. | Mar 8, 2023 | 1 | $50K | 4 | Mar 9, 2023 | CEO, Director |
UNCY | Unicycive Therapeutics, Inc. | Nov 21, 2022 | 1 | $0 | 4 | Nov 23, 2022 | CEO, Director |
UNCY | Unicycive Therapeutics, Inc. | Jul 15, 2021 | 1 | $0 | 4 | Jul 26, 2021 | CEO, Director |
UNCY | Unicycive Therapeutics, Inc. | Jul 12, 2021 | 0 | $0 | 3 | Jul 12, 2021 | CEO & President, Director |